Measures to assess adherence to inhaled corticosteroids for asthma Source: Eur Respir J 2003; 22: Suppl. 45, 294s Year: 2003
Suppression of F ENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice? Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019 Year: 2019
Clinical evolution of potroom asthma - effects of introducing montelukast to standard treatment with corticosteroid and beta-agonists Source: Eur Respir J 2001; 18: Suppl. 33, 278s Year: 2001
Baseline exhaled NO in relation to asthma control improvement after increased dose of inhaled steroids – A real-life study Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021
F ENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthmaSource: Eur Respir J, 55 (5) 2001319; 10.1183/13993003.01319-2020 Year: 2020
Meta-analysis of inhaled corticosteroids response in children with asthma. Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019
Monitoring asthma and adjusting the inhaled steroid dose: is there a better way? Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management Year: 2005
Clinical value of the immediate bronchodilator response to diagnose asthma in steroid-naïve adults Source: International Congress 2019 – Clinical implications of asthma management Year: 2019
Clinical value of bronchodilator response for diagnosing asthma in steroid-naïve adults Source: ERJ Open Res, 7 (4) 00293-2021; 10.1183/23120541.00293-2021 Year: 2021
Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD Source: Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019 Year: 2020
Pharmacogenetics of inhaled corticosteroid response in adults with asthma Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020
Effect of IgE sensitization and allergen exposure on exhaled NO during inhaled corticosteroid (ICS) treatment in patients with asthma Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007
Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
A study of exhaled NO (FENO) measurement used to determine asthma control, dose of inhaled corticosteroid and cost in a developing country Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015
Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007
Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004
Correlation between specific serum IgE and exhaled NO levels at low and high inhaled corticosteroid use in allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005
Evaluating the effects of inhaled corticosteroid on insulin sensitivity in asthmatic patients Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016
Relationship between omalizumab efficacy and baseline allergen profile impacts patient-reported outcomes in allergic asthma Source: International Congress 2018 – Tests and trends in asthma Year: 2018